🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Transthyretin Amyloid Cardiomyopathy

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM NCT07690436n/a20 sites📍 Palo Alto📍 Jacksonville📍 Chicago AstraZeneca Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy NCT07644325NA1 site📍 Montpellier Clinique Saint Jean, France · Tests: Annular ligament biopsy Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF NCT05577819NA1 site📍 Boston Massachusetts General Hospital · Tests: 99mTc-pyrophosphate Scintigraphy DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting NCT07358078n/a27 sites📍 Tucson📍 Beverly Hills📍 La Jolla Alnylam Pharmaceuticals Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites📍 Multiple Locations📍 Multiple Locations📍 Multiple Locations Bayer · Tests: Acoramidis (356 mg film-coated tablets) The Eplontersen Pregnancy and Lactation Outcomes Study NCT07205666n/a1 site📍 Frankfurt AstraZeneca Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis NCT07549841Phase 21 site📍 Nantes Nantes University Hospital · Tests: [68Ga]Ga-FAPI-46 A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis. NCT07448623Phase 11 site📍 Groningen Novo Nordisk A/S · Tests: Coramitug Comprehensive Program for Hereditary Transthyretin Amyloidosis NCT07213297n/a1 site📍 Canuelas Hospital de Alta Complejidad en Red · Tests: clinical assessments and complementary examinations Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis NCT04535349NA2 sites📍 Caen📍 Lille University Hospital, Caen · Tests: Whole-body & CZT bone tracer imaging (SPECT) Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy NCT07791160n/a1 site📍 Many Locations Bayer · Tests: Acoramidis The Italian Transthyretin Amyloidosis Web-Network NCT05444920n/a30 sites📍 Legnano📍 Orbassano📍 Ancona Fondazione IRCCS Policlinico San Matteo di Pavia Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis NCT07766135n/a1 site📍 Messina University of Messina Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy NCT06634108Phase 1, Phase 21 site📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Genistein A Phase 3 Study of NTLA-2001 in ATTRv-PN NCT06672237Phase 314 sites📍 Buenos Aires📍 Buenos Aires📍 San Juan Bautista Intellia Therapeutics · Tests: nexiguran ziclumeran, Normal Saline as Placebo Exercise Training in Transthyretin Cardiac Amyloidosis NCT05797857NA1 site📍 Boston Brigham and Women's Hospital · Tests: Exercise Training Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program NCT05040373n/a7 sites📍 Iowa City📍 Nantes📍 Münster Alnylam Pharmaceuticals ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) NCT04561518n/a40 sites📍 La Jolla📍 Los Angeles📍 Jacksonville Alnylam Pharmaceuticals US Benchmarking Clinical Study NCT07215715n/a3 sites📍 Boston📍 Boston📍 Boston eMyosound SAS NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis NCT06251778n/a1 site📍 Pavia Paolo Milani Thailand ATTR-CM Registry NCT06338696n/a8 sites📍 Bangkok📍 Bangkok📍 Bangkok Mahidol University · Tests: No intervention TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy NCT07223203Phase 361 sites📍 Aurora📍 Chicago📍 Baltimore Alnylam Pharmaceuticals · Tests: Nucresiran, Vutrisiran CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis NCT07207811Phase 3299 sites📍 Phoenix📍 La Jolla📍 Los Angeles Novo Nordisk A/S · Tests: NNC6019-0001, Placebo (NNC6019-0001) A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact. NCT06836011n/a8 sites📍 Graz📍 Vienna📍 Munich Medical University of Vienna Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis NCT06034405n/a6 sites📍 Beverly Hills📍 Boston📍 Boston Columbia University · Tests: Tc99-PYP or Tc99-HDMP Scan Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy NCT06082050EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: YOLT-201 Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis NCT05758493Phase 21 site📍 Portland Oregon Health and Science University · Tests: 124I-Evuzamitide Multimodality Cardiac Imaging for Disease Progression in ATTR-CM NCT07112066NA1 site📍 Zurich Dominik Benz · Tests: FAPI tracer Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy NCT04849754NA1 site📍 Lille GCS Ramsay Santé pour l'Enseignement et la Recherche · Tests: bone scintigraphy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy